The Aspirin-Guide app from researchers at Brigham and Women’s Hospital, Harvard Medical School, helps clinicians decide which patients are candidates for the use of low-dose aspirin (75 to 81 mg/d) in the primary prevention of atherosclerotic cardiovascular disease (ASCVD) by balancing the ASCVD benefits against the risk of harm due to gastrointestinal (GI) or other bleeding.
The app has several unique features, including:
*calculates a 10-year cardiovascular disease risk score (heart disease and stroke for the patient
*the ability to email a summary of the decision-making process to the patient
Aspirin-Guide incorporates information about the patient’s risk factors to calculate a 10-yr ASCVD risk score (the ACC/AHA ASCVD score) and a bleeding risk score, to help clinicians implement clinical guidelines on the use of aspirin in primary prevention.
Please note that research on aspirin in primary prevention among individuals younger than age 50 or 70 and older is limited.
A web-based version Aspirin-Guide is available at www.aspiringuide.com and is accessible from any computer or smartphone.
Bug fixes iOS 11
Ratings and ReviewsSee All
Useful app but... I do not see the major references for what it is based on. I know it is partially USPSTF. How long to continue aspirin? Need understanding of NNT and NNH
An Example of the Impressive Potential of Mobile Apps
This app offers helpful data points when deciding on whether to take aspirin regularly. I think it shows the potential of mobile apps to play important roles in helping us stay healthy.
Great tool and as a clinician it’s important to remember that no apps can override clinical judgement. Love the Info tab’s detail on the papers that have the evidence based medicine to back up the algorithm are easily accessible and a great resource when looking for details.
With Family Sharing set up, up to six family members can use this app.